
    
      A Phase 1b Open-Label, Randomized Study Evaluating the Absorption and Systemic
      Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-118 Lotion and
      HP Monad Lotion in Subjects with Moderate to Severe Plaque Psoriasis.
    
  